Alamar Biosciences, Inc.
NASDAQ:ALMRBiotechnology
Healthcare
$30.51 +5.50%
+$1.11 today
- Market cap
- $2.12B
- Beta
- 0.00
- P/E (TTM)
- -47.5
- EPS (TTM)
- -$0.45
52W Low $18.85High $27.20
Volume 0.53M
Average 0.38M
Income Statement
Follow revenue through to earnings.
Revenue
$74.21M
FY 2025 · Annual
Operating Income
-$31.33M
FY 2025 · Annual
Net Income
-$29.82M
FY 2025 · Annual
Income Statement
USD
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 74.21M |
| Cost of Revenue | 32.51M |
| Gross Profit | 41.71M |
| Gross Margin | 56.2% |
| Research & Development | 37.47M |
| Selling, General & Admin | 35.57M |
| Operating Expenses | 73.04M |
| Depreciation & Amortization | 3.86M |
| EBITDA | (24.89M) |
| EBITDA Margin | -33.5% |
| Operating Income | (31.33M) |
| Operating Margin | -42.2% |
| Interest Income | 2.16M |
| Interest Expense | 401K |
| Other Income / Expenses | 2.18M |
| Income Before Tax | (29.15M) |
| Pre-Tax Margin | -39.3% |
| Income Tax Expense | 665K |
| Net Income | (29.82M) |
| Net Margin | -40.2% |
| EPS (Basic) | (0.45) |
| EPS (Diluted) | (0.45) |
| 66.52M | |
| 66.52M |
ALMR Earnings Waterfall · TTM
NASDAQ:ALMR · Revenue to Net Income
No earnings data available.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 3, 2026 | |
| 8-K | Current report | Nov 3, 2026 |
How much revenue does ALMR generate?
Alamar Biosciences, Inc. (ALMR) reported $74.21M of revenue in fiscal 2025.
Is ALMR profitable?
Alamar Biosciences, Inc. (ALMR) reported -$29.82M of net income, with a net margin of -40.2%.
Continue the stock analysis
Jump to another research area for this company.